Last reviewed · How we verify
NCT06353451
Digital Detox Study: A Randomized Controlled Trial
NA trial testing Digital Detox in Health Behavior in 111 participants. Completed in 21 January 2024.
21 January 2024
Quick facts
| Lead sponsor | Danube University Krems |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 111 |
| Start date | 23 October 2023 |
| Primary completion | 21 January 2024 |
| Estimated completion | 21 January 2024 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Digital Detox
Conditions studied
- Health Behavior — all drugs for Health Behavior →
Sponsor
Danube University Krems
Who can join
Adults 18 to 29, any sex, with Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present RCT is to investigate the effect of smartphone screen time reduction on mental health indicators in healthy, 18-29 yo Austrian students. After inclusion and randomization to intervention- and control group, normal screen time behavior will be assessed for 10-days. After that, the mental health parameters will be carried out in both groups as a baseline survey (T0). After that, intervention group should limit smartphone screen time to less than 2 hours per day for three consecutive weeks. Control group should use smartphones as usual. After that, mental health parameters will be assessed again in both groups (post-intervention, T1). After T1, there are no further requirements regarding screen time. Mental health parameters will be assessed again in both groups at follow-up (T2). Main outcome parameters are 1) Well-Being (WHO-5), depressive symptoms (PHQ-9), stress (PSQ-20), and sleep quality (ISI). The primary hypothesis (stated at Open Science Framework before Enrollment: https://osf.io/a9k76) is that mental health indicators, particularly stress, depressive symptoms, and sleep quality will improve throughout the intervention compared to the control group as well as to baseline.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The influence of smartphone reduction on heart rate variability: a secondary analysis from a randomised controlled trial.
Dale R, Haider K, Majdandžić J, Hoenigl A, et al · · 2025 · cited 1× · PMID 40831581 · DOI 10.1080/21642850.2025.2546376 -
The influence of smartphone reduction on heart rate variability: a secondary analysis from a randomised controlled trial.
Dale R, Haider K, Majdandžić J, Hoenigl A, et al · · 2025 · DOI 10.31234/osf.io/s7khc_v1
Verify or expand the search:
- PubMed search for NCT06353451
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Health Behavior
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07248904 — The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea · NA · recruiting
- NCT07224412 — A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study · NA · recruiting
- NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals · NA · recruiting
- NCT07226271 — Consumer Perceptions of Alcoholic Beverages · NA · recruiting
Other Danube University Krems trials
Trials by the same sponsor.
- NCT06910371 — Digital Detox Study · NA · not yet recruiting
- NCT03852173 — Effects of a School-based Intervention to Increase the Water Consumption in Elementary School Children · NA · completed
- NCT03694574 — Emotion Regulation in Trait Schizotypy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06353451 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danube University Krems
- Last refreshed: 9 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06353451.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing